Clearmind Medicine CMND
NASDAQ CMND
$6.00 +0.01 (+0.08%)
As of: Oct 22, 2026 · 3:27 PM EDT

Clearmind Medicine (CMND) Return on Sales [ROS] (2023 - 2026)

Updated

Clearmind Medicine's Return on Sales [ROS] came in at -4180.53% for FY2022 (year ended Oct 31, 2022), down 1568.02 percentage points from -2612.51% in FY2021.

Analysis

Clearmind Medicine (CMND) Return on Sales [ROS] (2023 - 2026) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Return on Sales [ROS] at -2612.51% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 24.35%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 37.86%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 20.57%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 28.37%
10 Clearmind Medicine 9,534.00 -39.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2026 -576.23%
Oct 31, 2025 -88.97%
Jul 31, 2025 -1,274.37%
Jan 31, 2025 -222.53%
Oct 31, 2024 -98.63%
Apr 30, 2024 -201.71%
Jul 31, 2023 -111.66%
Apr 30, 2023 -34,648.26%
Jan 31, 2023 -6,703.75%
API Access

Clearmind Medicine Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CMND&period=max&api_key=YOUR_API_KEY